⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
globenewswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY Investors with Losses in Excess of $100K Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
prnewswire.com
SPRY
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
SPRY LAWSUIT ALERT: Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. Investors - Lead Plaintiff Deadline October 5, 2026
accessnewswire.com
SPRY
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm
prnewswire.com
SPRY
SPRY DEADLINE: The Gross Law Firm Reminds ARS Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline
prnewswire.com
SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
SPRY
ARS Pharmaceuticals, Inc. (SPRY) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 5, 2026 Deadline
accessnewswire.com
SPRY